Pharmagen, Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a PHRX research report →
Companywww.pharmageninc.com
Pharmagen, Inc. distributes specialty drugs to hospitals, acute care facilities, surgery centers, and other healthcare practitioners in the United States. The company sources and distributes specialty drugs, blood plasma derivatives, specialty products, vaccines, anti-infectives, and hard-to-find pharmaceuticals.
- CEO
- Mackie A. Barch
- IPO
- 2012
- Employees
- 24
- HQ
- Silver Spring, MD, US
Price Chart
Valuation
- Market Cap
- $5.17K
- P/E
- -0.00
- P/S
- 1.07
- P/B
- -0.00
- EV/EBITDA
- -0.00
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 63.27%
- Op Margin
- -44.86%
- Net Margin
- -134.17%
- ROE
- 85.12%
- ROIC
- 73.04%
Growth & Income
- Revenue
- $4.81K · 0.00%
- Net Income
- $-6,457.614 · 0.00%
- EPS
- $-0.02 · 0.00%
- Op Income
- $-2,159.028
- FCF YoY
- 0.00%
Performance & Tape
- 52W High
- $0.00
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- 0.32
- Avg Volume
- 10.91K
Get TickerSpark's AI analysis on PHRX
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jun 30, 14 | SKIBSTED RUSSELL | other | 0 |
| Jun 9, 14 | SKIBSTED RUSSELL | other | 0 |
Our PHRX Coverage
We haven't published any research on PHRX yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate PHRX Report →